SAMANTHA GARBER: Open Payments
NPI 1871284885 · BROOKSVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$758 in 35 payments from 11 companies in 2025. Trend: 2023 $623 · 2024 $1,353 · 2025 $758
Food & beverage: $758
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $132 |
| ABBVIE INC. | 5 | $104 |
| Alkermes, Inc. | 4 | $89 |
| Almatica Pharma LLC | 4 | $87 |
| E.R. Squibb & Sons, L.L.C. | 3 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| Vanda Pharmaceuticals Inc. | 3 | $66 |
| Indivior Inc. | 3 | $55 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
Products named: CAPLYTA, VRAYLAR, LOREEV XR, COBENFY, REXULTI, ARISTADA, SUBLOCADE, HETLIOZ.
Industry payments across FL — which companies pay providers there.
